NUP214 and acute myeloid leukemia: DEK was originally identified in acute myeloid leukemia as a fusion protein with NUP214 [1], and was subsequently shown to be overexpressed at the mRNA and protein levels in various cancer types including squamous cell carcinoma (SCC) [2–7].